Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06858787 · ClinicalTrials.gov registry record · NA
Validating CGM for GDM
A NA study of Gestational Diabetes Mellitus (GDM), sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT06858787: Recruiting NA study of Gestational Diabetes Mellitus (GDM), sponsored by Icahn School of Medicine at Mount Sinai.
NCT06858787 is a NA study of Gestational Diabetes Mellitus (GDM) that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 150 participants, below the 806-participant average among 4 other Gestational Diabetes Mellitus (GDM) trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06858787, a NA study of Gestational Diabetes Mellitus (GDM), is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
Primary Outcome
Blood glucose aggregate values from Dexcom G7 continuous glucose monitor (CGM)
Conditions Studied
Interventions
- DEVICE Continuous glucose monitor
Study Locations (2)
New York
- Icahn School of Medicine at Mount Sinai - New York
- Mount Sinai South Nassau - Oceanside
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-10-02 |
| Est. Completion | 2028-04 |
| Phase | NA |
What NCT06858787 shows while recruiting
NCT06858787 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 806-participant average among 4 other Gestational Diabetes Mellitus (GDM) trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Gestational Diabetes Mellitus (GDM) appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitor is the first listed.
NCT06858787 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06858787 about?
NCT06858787 is a clinical study titled "Validating CGM for GDM". This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice ...
What is the current status of trial NCT06858787?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-10-02. Estimated completion is 2028-04.
What conditions does trial NCT06858787 study?
This clinical trial studies the following conditions: Gestational Diabetes Mellitus (GDM).
What interventions are being tested in trial NCT06858787?
The interventions under investigation include: Continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT06858787?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06858787 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes Mellitus (GDM)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
RECRUITING · NA
-
Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
RECRUITING · NA
-
The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy
RECRUITING · Phase 1
-
Maternal Obesity, Breast Milk Composition, and Infant Growth
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI